Altamira Therapeutics Market Cap

Altamira Therapeutics has a market cap or net worth of $570.98 thousand as of August 15, 2025. Its market cap has decreased by -80.09% in one year.

Market Cap

570.98K

Enterprise Value

-66.60K

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.10

Market Cap Chart

Since August 8, 2014, Altamira Therapeutics's market cap has decreased from 171.70M to 570.98K, a decrease of -99.67%. That is a compound annual growth rate of -40.40%.

Market Cap History

Date	Market Cap	% Change
Aug 14, 2025	442.78K	17.80%
Dec 31, 2024	375.87K	-72.84%
Dec 29, 2023	1.38M	-75.59%
Dec 30, 2022	5.67M	-78.93%
Dec 31, 2021	26.91M	-10.02%
Dec 31, 2020	29.91M	459.11%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Nika Pharmaceuticals	972.72M
Veradigm	789.71M
Tian'an Technology Group	628.15M
Elite Pharmaceuticals	608.19M
Glass House Brands	543.74M
American Oncology Network	393.37M
Northwest Biotherapeutics	332.06M
CytoDyn	300.87M

Market Cap Rankings